Interestingly, ERG is implicated several of these processes as part of its normal function and thus differences in Ras/ERK or PI3K/AKT signaling may dictate ERG function both when aberrantly expressed in prostate cancer and in its normal physiological role. This evidence concerns the gene MAPK1 and prostate cancer.